PMC:7696151 / 56103-56297
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1620 | 32-35 | Chemical | denotes | HCQ | MESH:D006886 |
| 1621 | 71-78 | Chemical | denotes | aspirin | MESH:D001241 |
| 1622 | 83-90 | Chemical | denotes | heparin | MESH:D006493 |
| 1634 | 137-147 | Disease | denotes | thrombosis | MESH:D013927 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T361 | 0-194 | Sentence | denotes | The addition of 400 mg daily of HCQ to a common therapeutic regimen of aspirin and heparin dramatically reduced the episodes of vascular thrombosis [96], showing great antithrombotic properties. |